Literature DB >> 2722339

Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement.

Y al-Gindan1, R Kubba, A M el-Hassan, A H Omer, M K Kutty, M B Saeed.   

Abstract

In a study of zoonotic cutaneous leishmaniasis (CL) due to leishmania major in an endemic focus in Saudi Arabia, lymph node enlargement was observed in 66 of 643 patients (10.26%). The epitrochlear lymph nodes were most commonly involved (68%), but cervical (11%), axillary (15%), and inguinal (18%) lymph nodes were also involved. In eight patients (12%), two lymph node areas were involved. The affected lymph nodes were typically solitary, firm, mobile, nontender, only moderately enlarged, and appeared to persist beyond the clinical healing of the associated skin lesions. The results of pathologic and immunopathologic studies carried out on eight lymph nodes obtained from this group of patients supported the leishmanial etiology. Although amastigotes were only demonstrated in two lymph nodes, the leishmanial antigen was found in all eight specimens. The lymph node involvement is another manifestation of dissemination in infection with a dermotropic leishmania. It appears that in some cases, instead of the parasite, it may be the leishmanial antigen that disseminates and produces lymphadenitis.

Entities:  

Mesh:

Year:  1989        PMID: 2722339     DOI: 10.1111/j.1365-4362.1989.tb04814.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.

Authors:  Roger Adrian Figueroa; Leyder Elena Lozano; Ibeth Cristina Romero; Maria Teresa Cardona; Martin Prager; Robinson Pacheco; Yira Rosalba Diaz; Jair Alexander Tellez; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

Authors:  Pieter-Paul van Thiel; Tjalling Leenstra; Henry J de Vries; Allard van der Sluis; Tom van Gool; Alex C Krull; Michèle van Vugt; Peter J de Vries; Jimmy E Zeegelaar; Aldert Bart; Wendy F van der Meide; Henk D F H Schallig; William R Faber; Piet A Kager
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

4.  Leishmania major infection in a dog with cutaneous manifestations.

Authors:  Gad Baneth; Yaarit Nachum-Biala; Maytal Shabat Simon; Ori Brenner; Sarit Gaier; Alicia Rojas; Daniel Yasur-Landau
Journal:  Parasit Vectors       Date:  2016-05-10       Impact factor: 3.876

Review 5.  Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview.

Authors:  Abuzaid A Abuzaid; Abdalmohsin M Abdoon; Mohamed A Aldahan; Abdullah G Alzahrani; Raaft F Alhakeem; Abdullah M Asiri; Mohamed H Alzahrani; Ziad A Memish
Journal:  Vector Borne Zoonotic Dis       Date:  2017-08-14       Impact factor: 2.133

6.  Clinical significance and epidemiological evolution of epitrochlear lymphadenopathy in pre- and post-highly active antiretroviral therapy era: A systematic review of the literature.

Authors:  Valliappan Muthu; Inderpaul Singh Sehgal; Sahajal Dhooria; Ritesh Agarwal
Journal:  Lung India       Date:  2018 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.